The relationships between CYP4F2 genotypes, plasma α-tocopherol levels at baseline and weeks 48 (w48) and 96 (w96) and histological end points (overall improvement in liver histology and resolution of NASH) were investigated. The gene discussed is CYP4F2; the disease is metabolic dysfunction-associated steatohepatitis.